钆塞酸二钠动态增强MRI无创诊断门静脉高压:肝脏与脾脏评估
本研究前瞻性纳入35例慢性肝病患者,评估钆塞酸二钠动态增强MRI肝脏和脾脏参数对门静脉高压(PH)及临床显著门静脉高压(CSPH)的无创诊断价值。
要点
- 肝脏摄取率ki是诊断PH的最佳单一参数,AUC 0.74,敏感度71.4%,特异度78.6%。
- 肝脏ki联合脾脏间质分数ve诊断CSPH的AUC达0.87,敏感度100%,特异度73.1%。
- 肝脏摄取参数与脾脏间质分数均与肝静脉压力梯度(HVPG)显著相关。
诊断标准与关键数值
- PH定义为HVPG>5 mmHg,CSPH定义为HVPG≥10 mmHg。
临床应用与阅片要点
- 可关注钆塞酸二钠DCE-MRI肝脏摄取率ki和脾脏间质分数ve,二者与HVPG相关,有助于无创评估门静脉高压。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To assess the performance of gadoxetate dynamic contrast-enhanced (DCE) MRI of the liver and spleen for noninvasive diagnosis of portal hypertension (PH).
METHODS: Thirty-five patients (M/F 22/13, mean age 55 years) with chronic liver disease who underwent hepatic venous pressure gradient (HVPG) measurements were prospectively enrolled in this IRB-approved study. All patients underwent multiparametric MRI including gadoxetate DCE-MRI acquisition. Model-based and model-free DCE-MRI analyses were performed. The correlation between DCE-MRI parameters and HVPG was assessed. ROC analysis was employed to determine the diagnostic performance of DCE-MRI parameters alone and in combination for prediction of PH and clinically significant (CS)PH (HVPG > 5 and ≥ 10 mmHg, respectively).
RESULTS: Mean HVPG was 7.0 ± 5.0 mmHg (range 0-18 mmHg). Twenty-one (60%) patients had PH, of whom 9 had CSPH. Modeled liver uptake fraction fi and uptake rate ki and model-free parameters liver upslope and uptake were all significantly negatively correlated with HVPG (r range - 0.490 to - 0.398, p value range 0.003-0.018), while spleen interstitial fraction ve was significantly positively correlated with HVPG (r = 0.336, p = 0.048). For PH diagnosis, liver ki showed the best diagnostic performance with an AUC, sensitivity, and specificity of 0.74 (confidence interval (CI) 0.57-0.91), 71.4%, and 78.6%. The combination of liver ki and spleen ve was selected as the best classifier for diagnosis of CSPH with an AUC, sensitivity, and specificity of 0.87 (CI 0.75-0.99), 100%, and 73.1%.
CONCLUSIONS: Our results demonstrate the potential utility of hepatocyte uptake parameters and spleen interstitial fraction obtained with gadoxetate DCE-MRI for the diagnosis of PH and CSPH.
KEY POINTS: • Liver uptake and spleen interstitial fraction estimates from gadoxetate DCE-MRI are significantly correlated with portal pressure measurements. • Liver uptake rate shows good diagnostic performance for the diagnosis of portal hypertension. • The combination of liver uptake rate with spleen interstitial fraction exhibits excellent diagnostic performance for the diagnosis of clinically significant portal hypertension.
引用
- Hectors SJ, Bane O, Kennedy P, et al. Noninvasive diagnosis of portal hypertension using gadoxetate DCE-MRI of the liver and spleen. Eur Radiol. 2021. PMID: 33411050. doi:10.1007/s00330-020-07495-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。